HumeCare+ Reviews: Pros, Cons and the Refund Fine Print, and What Real Buyers Say Before Starting
Every telehealth program looks good on its own landing page. The harder question is what the Terms of Service actually promise once you've committed a card number. Here's the honest scorecard for HumeCare+ — the trade-offs worth knowing, the fine print on the guarantee, and who should skip it entirely.
The scorecard, the real guarantee terms, and the honest verdict.
In This Article
Buyer Verdict
What do HumeCare+ buyers report? Start with where the numbers come from: there's no independent review page for this service, so what exists is the company's own count — 4.7 out of 5 across roughly 21,479 testimonials, self-reported. Read that as marketing you can inspect, not as verified feedback. What the testimonials consistently describe is appetite dropping in the first weeks and steady loss after that, which is what the trial data on these molecules would predict.
The complaints are more useful, and they aren’t about the medication. They’re about paperwork: a non-refundable consultation fee that appears on no pricing page, and a results guarantee written three different ways across the homepage, the landing page and the Terms of Service. That gap is what keeps our score at 4.6/5 rather than higher — and it’s why it’s worth applying if you have a BMI of 27+, have never used a GLP-1, and can self-pay, and worth skipping if you’ve used one before (the guarantee excludes you), live in one of the four unserved states, or need insurance to cover it.
THE CORE PROMISE
The pitch is simple: skip the four-figure pharmacy price tag, get a real evaluation from a real clinician, and — if approved — receive compounded semaglutide or tirzepatide at your door for $199 or $299 a month, with a smart scale and app to track it. Whether it delivers on that pitch honestly is a different question from whether the drug class works — the trial data on semaglutide and tirzepatide themselves is strong. This page is about the company's own claims, not the pharmacology.
1. What the Company's Own Numbers and Fine Print Tell You
HumeCare+ doesn't have an independent third-party review archive the way a supplement sold on its own storefront often does — what exists is the company's self-reported testimonial count (4.7/5 across roughly 21,479 reviews, by its own count) and its own Terms of Service, which is where the real conditions live. Treat the pattern below as what those two sources actually say, not as audited buyer sentiment:
| What people ask before applying | What the company's own materials say | What it tells you |
|---|---|---|
| "Is this cheaper than Ozempic?" | $199 or $299 a month, self-pay, no insurance accepted. The homepage doesn't compare it to any specific brand-name price. | It's a genuinely lower cash outlay than the injectable brand names typically run, but confirm the exact number for your situation before assuming a specific savings figure. |
| "What does the guarantee actually cover?" | Three different descriptions across three pages: the homepage says "lose 10% in 6 months or refund," the landing page says "180 days," and the Terms of Service say 90 days with a "any measurable weight loss" bar — plus first-time-user, zero-missed-dose, and 13-weigh-in conditions. | The Terms of Service is the version that legally governs. Read §7 of our price page before you count on the marketing language. |
| "Is there a hidden fee?" | Yes — the Terms disclose a non-refundable "clinical consultation fee assessed at enrollment and each refill." The amount isn't published on the homepage, the landing page, or the checkout screens. | Ask for the exact figure at checkout before you commit. It applies every refill, not just once. |
| "Am I even eligible?" | 46 states plus D.C. (not Alabama, Arkansas, Louisiana or Mississippi), self-pay only, and approval isn't guaranteed — Hume states this directly in its own Terms. | Check your state before you apply, and go in knowing the evaluation can end without a prescription. |
Skip HumeCare+ if…
you've already used any GLP-1 medication, compounded or brand-name (you won't qualify for the results guarantee, and possibly not for enrollment), you live in Alabama, Arkansas, Louisiana or Mississippi, or you need insurance, Medicare or Medicaid to cover the cost — HumeCare+ is self-pay only.
2. Scorecard Across 6 Criteria
| Criterion | Score | Notes |
|---|---|---|
| Real medication & clinical oversight | 4.8/5 | Genuine compounded semaglutide or tirzepatide, prescribed by an independent Clinical Network of licensed U.S. clinicians — not a mimetic and not a self-serve pharmacy. |
| Evidence behind the drug class | 4.7/5 | STEP 1 and SURMOUNT-1 are large randomized trials with real results. They tested the FDA-approved brand, not this compounded version — the one honest asterisk. |
| Price & value | 4.6/5 | $199–$299/month undercuts the injectable brand-name cash price by a wide margin, but the undisclosed consultation fee dents the value math. |
| Guarantee clarity | 4.2/5 | A real 90-day guarantee exists in the Terms of Service, but the homepage and landing page each describe a different version of it — that inconsistency is the main drag on this score. |
| Access & eligibility | 4.5/5 | 46 states plus D.C. is broad coverage for a compounding telehealth program, though self-pay-only and no insurance narrows who it's realistic for. |
| Regulatory transparency | 4.4/5 | The homepage displays CQC and MHRA regulatory badges — U.K. regulators with no jurisdiction over a service the Terms describe as U.S.-only. That's a real transparency miss. |
Average across criteria: 4.6/5 — the medication and the clinical process are genuinely strong; what pulls the average down is inconsistency in the company's own marketing, not the program itself.
3. What the Company's Testimonials and Terms Reveal
HumeCare+ cites 20,000+ members and a self-reported 4.7/5 across roughly 21,479 reviews on its own homepage — a real volume signal, though it's the company's own count and not independently audited, so read it as "a lot of people have been through this process," not as a verified rating. Alongside that number, a few honest patterns come straight from the company's own published materials:
- Individual results vary, and the company says so. The homepage’s before-and-after figures carry their own “individual results may vary” disclaimer — a normal caveat, worth taking at face value rather than assuming everyone’s curve matches the marketing chart.
- The marketing timeline is optimistic; the trial data is the more conservative read. HumeCare+‘s own 0–3/3–6/6–12-month curve broadly tracks what STEP 1 and SURMOUNT-1 showed at comparable points — but those trials ran on the FDA-approved brand, not the compounded version members actually receive.
- The named medical leadership is real. The site names a Chief Medical Officer and a Weight Loss Specialist Prescriber by title — a stronger transparency signal than an anonymous “our doctors” claim, though we didn’t independently verify their credentials beyond what’s published.
4. HumeCare+ Pros
- Real prescription medication — compounded semaglutide or tirzepatide, not a supplement mimicking the drug class
- Independent Clinical Network — licensed U.S. clinicians actually evaluate you; Hume itself doesn’t practice medicine
- The drug class has strong trial data — STEP 1 and SURMOUNT-1 established semaglutide and tirzepatide work for weight loss
- Tirzepatide plan adds B12 and glycine — aimed at the muscle-loss trade-off the GLP-1 research documents
- App and Hume Pod smart scale included — dose logging and weigh-in tracking built into the membership
- Cancel anytime with 48 hours’ notice — no long-term contract
- Self-pay price well under the injectable brand names — $199 or $299 a month
- Three different guarantee descriptions across three pages — the Terms of Service (90 days, first-time GLP-1 users, zero missed doses, 13 weekly weigh-ins) is the version that governs, not the homepage banner
- An undisclosed consultation fee applies at enrollment and every refill and isn’t listed anywhere on the site
- Self-pay only — no insurance, Medicare or Medicaid accepted
- Not available everywhere — Alabama, Arkansas, Louisiana and Mississippi are excluded
- Approval isn’t guaranteed — the Clinical Network can decline you at the initial evaluation
5. HumeCare+ Cons
Restated plainly, so nothing above reads as buried: the medication and the clinical process behind it are legitimate. What costs HumeCare+ points is transparency — the guarantee language doesn't match itself across the company's own pages, and a real fee is left off every price list. Neither issue is about whether the drug works.
6. Worth It For Whom?
Worth applying for someone who qualifies medically (BMI 27+, no prior GLP-1 use), can pay out of pocket, and wants a real clinical evaluation instead of gambling on an unnamed online pharmacy. The price genuinely undercuts the brand-name injectable, and the Clinical Network structure is a legitimate safeguard, not window dressing. Not worth it for someone who needs insurance to cover the cost, has already used a GLP-1 drug (the guarantee won't apply, and eligibility itself may be affected), or lives in one of the four unserved states. Read the full label reality, including the evidence behind the drug class, in the full HumeCare+ review before you apply.
Pricing Options for HumeCare+
Your provider titrates the dose over the first several weeks, so one month tells you about tolerance, not results. The 90-day guarantee sits outside that window for first-time GLP-1 users. Given all of that, budgeting for at least three months is the honest way to judge this membership.
Semaglutide Injections
Monthly Membership
- Compounded semaglutide injections
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
Oral Semaglutide
Monthly Membership
- Compounded oral semaglutide
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
Tirzepatide + B12 + Glycine
Monthly Membership
- Compounded tirzepatide + B12 + glycine
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
A separate, non-refundable consultation fee applies at enrollment and each refill; confirm the amount at checkout. The 90-Day Weight Loss Results Guarantee applies to first-time GLP-1 users who meet every condition in the Terms of Service.
Frequently Asked Questions
What's the most common concern about HumeCare+?
The gap between the marketing and the fine print — the guarantee reads generously on the homepage and much more narrowly in the Terms of Service, and a real consultation fee isn't printed anywhere. Neither issue is about whether the medication itself works.
Is the "clinically proven medication" language on the site accurate?
The drug class is clinically proven at the FDA-approved brand-name dose — STEP 1 and SURMOUNT-1 are real, large trials. The compounded version HumeCare+ ships hasn't been independently trial-tested itself, and the FDA has stated it hasn't reviewed compounded GLP-1s for safety, efficacy or manufacturing quality. Both things are true at once.
Who should skip HumeCare+?
Anyone who's already used a GLP-1 medication (the results guarantee won't apply, and it may affect eligibility), anyone in Alabama, Arkansas, Louisiana or Mississippi, and anyone who needs insurance, Medicare or Medicaid to cover the cost — HumeCare+ is self-pay only.
Continue your research
- Address: Full review — the evidence behind the drug class and how the program works
- Then: Pricing breakdown — the real guarantee terms and the hidden fee
- Compare: GLP-1 Plus — a non-prescription route to the same appetite pathway
Research & Transparency
This content is based on publicly available clinical trial data, FDA and CDC publications, and HumeCare+'s own Terms of Service and program materials. We are not affiliated with Hume Health Care LLC.
(a) Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 2021
(b) Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022
(c) FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov
About the Author
Luciano Andreoti is a contributor at The Supplement Post, supporting the production of evidence-aware supplement and wellness-program reviews across multiple health categories. His work spans ingredient and program analysis, formulation and process assessment, and consumer-oriented summaries — what a company discloses, how its stated terms compare with what it actually publishes, and whether the offer matches what it claims to do. Every review is checked by The Supplement Post editorial team against the standards published in our editorial policy before it goes live.
Disclosure
All content is for informational purposes only and is not a substitute for professional medical advice. The program reviewed here dispenses a prescription medication only after an independent clinical evaluation — it is not a dietary supplement, and approval is not guaranteed. Results may vary based on individual health status and consistency of use. This page may contain affiliate links — if you purchase through them, we may earn a small commission at no additional cost to you. Read our Editorial Policy.